Perioperative Management & Outcome Following Preoperative Transthoracic Echocardiography in Noncardiac Surgery Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Transthoracic Echocardiography Recieved.
- Who it may be relevant to
- Registry conditions: Elective Surgical Procedure. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
EuPreCHO: European Study on Perioperative Management and Outcome Following Preoperative Transthoracic Echocardiography in Noncardiac Surgery Patients
Overview
In August 2022 the European Society of Cardiology published updated guidelines including recommendations on preoperative transthoracic echocardiography. The update resulted in broadened criteria for preoperative transthoracic echocardiography. The impact of preoperative transthoracic echocardiography on outcome is controversial and the evidence was mostly derived from administrative databases. Also there is also a knowledge gap in terms of what changes in perioperative managements are derived from transthoracic echocardiography information in current daily practice in Europe and what their impact on outcome may be. Further, a secondary analysis in a large international cohort suggests that the criteria endorsed by the guidelines to define the class of recommendation of transthoracic echocardiography may not be efficient.
Detailed description
The target population consists of patients at elevated cardiovascular risk undergoing elective, intermediate or high-risk noncardiac surgery. The planned sample size is 5500 exposed and 2750 non-exposed
Interventions
- Other Transthoracic Echocardiography Recieved
Transthoracic Echocardiography Recieved
Primary outcome measures
- Major Pathology [Time frame: 30 days]
Secondary outcome measures (1)
- Disability-free survival at 30 days [Time frame: 30 days]
Eligibility criteria
Inclusion criteria
- aged ≥65 years OR
- above 18 years and presenting ≥2 cardiovascular risk factors (hypertension, smoking, dyslipidaemia, diabetes, family history of CVD) OR
- above 18 years with known cardiovascular disease
Exclusion criteria
- under 18 years of age
- day surgery
- urgent/emergency procedures
- current ICU patient (i.e. in ICU on day-1 or the day of the index surgery (day 0)),
- cardiac surgery within the last month prior according to the index noncardiac procedure (of note this does not include cardiological interventions like TAVI or valvuloplasty),
- unwilling or unable to provide informed consent,
- unable to complete the WHODAS questionnaire (literacy or language barrier)
- Previous enrollment in EuPreCHO (in case of repeated surgery)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-control
Study locations
Germany · 1 center
- University Hospital Düsseldorf — Düsseldorf
Identifiers
NCT: NCT06409234 · EuPreCHO